The association of insulin-like-growth factor 1 (IGF-1) with incident coronary heart disease in women: Findings from the prospective British Women's Heart and Health Study

Atherosclerosis

Volumn 201, Issue 1, 2008, Pages 198-204

  Lawlor, Debbie A ^a   Ebrahim, Shah ^b   Smith, George Davey ^a   Cherry, Lynne ^c   Watt, Pauline ^c   Sattar, Naveed ^c  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

CHD; Epidemiology; IGF 1; Women

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; SOMATOMEDIN C;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; GENETIC EPIDEMIOLOGY; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; SMOKING; SOCIAL STATUS; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; UNITED KINGDOM; WAIST HIP RATIO;

AGE FACTORS; AGED; BLOOD GLUCOSE; BLOOD PRESSURE; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; COHORT STUDIES; CORONARY DISEASE; FEMALE; GREAT BRITAIN; HUMANS; INCIDENCE; INSULIN-LIKE GROWTH FACTOR I; LIPIDS; MIDDLE AGED; RISK FACTORS;

EID: 54049140457     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.12.061     Document Type: Article

References (32)

1. Hwa V., Oh Y., and Rosenfeld R.G. The insulin-like growth factor-binding protein (IGFBP) superfamily. Endocr Rev 20 (1999) 761-787
2. Jones J.I., and Clemmons D.R. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16 (1995) 3-34
3. Sandhu M.S., Heald A.H., Gibson J.M., Cruickshank J.K., Dunger D.B., and Wareham N.J. Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study. Lancet 359 (2002) 1740-1745
4. Holt R.I.G., Simpson H.L., and Sonksen P.H. The role of the growth hormone-insulin-like growth factor axis in glucose homeostasis. Diabet Med 20 (2003) 3-15
5. Chan J.M., Stampfer M.J., Giovannucci E., et al. Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 279 (1998) 563-566
6. Hankinson S.E., Willett W.C., Colditz G.A., et al. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 351 (1998) 1393-1396
7. Ma J., Pollak M.N., Giovannucci E., et al. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-1 and IGF-binding protein-3. J Natl Cancer Inst 91 (1999) 620-625
8. Stattin P., Bylund A., Rinaldi S., et al. Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study. J Natl Cancer Inst 92 (2000) 1910-1917
9. Palmqvist R., Hallmans G., Rinaldi S., et al. Plasma insulin-like growth factor 1, insulin-like growth factor binding protein 3, and risk of colorectal cancer: a prospective study in northern Sweden. Gut 50 (2002) 642-646
10. Pollak M.N., Schernhammer E.S., and Hankinson S.E. Insulin-like growth factors and neoplasia. Nat Rev Cancer 4 (2004) 505-518
11. Hunt K.J., Lukanova A., Rinaldi S., et al. A potential inverse association between insulin-like growth factor I and hypertension in a cross-sectional study. Ann Epidemiol 16 (2006) 563-571
12. Janssen J.A., Stolk R.P., Pols H.A., Grobbee D.E., and Lamberts S.W. Serum total IGF-I, free IGF-I, and IGFB-1 levels in an elderly population: relation to cardiovascular risk factors and disease. Arterioscler Thromb Vasc Biol 28 (1998) 277-282
13. Heald A.H., Cruickshank J.K., Riste L.K., et al. Close relation of fasting insulin-like growth factor binding protein-1 (IGFBP-1) with glucose tolerance and cardiovascular risk in two populations. Diabetologia 44 (2001) 333-339
14. Hussain M.A., Schmitz O., Mengel A., et al. Insulin-like growth factor I stimulates lipid oxidation, reduces protein oxidation, and enhances insulin sensitivity in humans. J Clin Invest 92 (1993) 2249-2256
15. Spallarossa P., Brunelli C., Minuto F., et al. Insulin-like growth factor-I and angiographically documented coronary artery disease. Am J Cardiol 77 (1996) 200-202
16. Goodman-Gruen D., Barrett-Connor E., and Rosen C. IGF-1 and ischemic heart disease in older people. J Am Geriatr Soc 48 (2000) 860-861
17. Botker H.E., Skjaerbaek C., Eriksen U.H., Schmitz O., and Orskov H. Insulin-like growth factor-I, insulin, and angina pectoris secondary to coronary atherosclerosis, vasospasm, and syndrome X. Am J Cardiol 79 (1997) 961-963
18. Juul A., Scheike T., Davidsen M., Gyllenborg J., and Jorgensen T. Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: a population-based case-control study. Circulation 106 (2002) 939-944
19. Laughlin G.A., Barrett-Connor E., Criqui M.H., and Kritz-Silverstein D. The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: the Rancho Bernardo Study. J Clin Endocrinol Metab 89 (2004) 114-120
20. Harrela M., Qiao Q., Koistinen R., et al. High serum insulin-like growth factor binding protein-1 is associated with increased cardiovascular mortality in elderly men. Horm Metab Res 34 (2002) 144-149
21. Lawlor D.A., Bedford C., Taylor M., and Ebrahim S. Geographic variation in cardiovascular disease, risk factors and their control in older women: British Women's Heart and Health Study. J Epidemiol Community Health 57 (2003) 134-140
22. Lawlor D.A., Davey Smith G., Ebrahim S., Thompson C., and Sattar N. Plasma adiponectin levels are associated with insulin resistance but do not predict future risk of coronary heart disease in women: findings from the British Women's Heart and Health Study. J Clin Endocrinol Metabol 90 (2005) 5677-5683
23. Lawlor D.A., Davey Smith G., and Ebrahim S. Does the new International Diabetes Federation definition of the metabolic syndrome predict CHD any more strongly than older definitions? Findings from the British Women's Heart and Health Study. Diabetologia 49 (2006) 41-48
24. Prentice R.L., and Breslow N.E. Retrospective studies and failure time models. Biometika 65 (1978) 153-158
25. Rothman K.J., and Greenland S. Modern epidemiology. 2nd ed. (1998), Lippincott-Raven, Philadelphia
26. Wetterau L.A., Moore M.G., Lee K.W., Shim M.L., and Cohen P. Novel aspects of the insulin-like growth factor binding proteins. Mol Genet Metab 68 (1999) 161-181
27. Allison D.B., Gallagher D., Heo M., Pi-Sunyer F.X., and Heymsfield S.B. Body mass index and all-cause mortality among people age 70 and over: the longitudinal study of aging. Int J Obes Relat Metab Disord 21 (1997) 424-431
28. Dey D.K., Rothenberg E., Sundh V., Bosaeus I., and Steen B. Body mass index, weight change and mortality in the elderly. A 15 y longitudinal population study of 70 y olds. Eur J Clin Nutr 55 (2001) 482-492
29. Visscher T.L.S., Seidell J.C., Molarius A., van der Kuip D., Hofman A., and Witteman J.C.M. A comparison of body mass index, waist-hip ratio and waist circumference as predictors of all-cause mortality among the elderly: the Rotterdam Study. Int J Obes 25 (2001) 1730-1735
30. Frystyk J., Ledet T., Moller N., Flyvbjerg A., and Orskov H. Cardiovascular disease and insulin-like growth factor I. Circulation 106 (2002) 893-895
31. Sandhu M.S. Insulin-like growth factor-I and risk of type 2 diabetes and coronary heart disease: molecular epidemiology. Endocr Dev 9 (2005) 44-54
32. Davey Smith G., and Ebrahim S. Mendelian randomisation: can genetic epidemiology contribute to understanding environmental determinants of disease?. Int J Epidemiol 32 (2003) 1-22